Wildcat Capital Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SPDR Gold Trust
GLD
|
+$16.3M |
| 2 |
Allogene Therapeutics
ALLO
|
+$14.8M |
| 3 |
iShares National Muni Bond ETF
MUB
|
+$4.55M |
| 4 |
Meta Platforms (Facebook)
META
|
+$4.48M |
| 5 |
Cameco
CCJ
|
+$4.03M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
LPL Financial
LPLA
|
+$7.08M |
| 2 |
CoStar Group
CSGP
|
+$6.68M |
| 3 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$2.17M |
| 4 |
NH
NantHealth, Inc
NH
|
+$80.4K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Real Estate | 28.86% |
| 2 | Healthcare | 22.88% |
| 3 | Energy | 8.73% |
| 4 | Communication Services | 5.56% |
| 5 | Consumer Discretionary | 5.55% |
Similar funds
Wildcat Capital Management's Q2 2019 Portfolio in Review
As of Q2 2019, Wildcat Capital Management held 32 positions worth $231M, up 35% from $171M the previous quarter. Its ten largest holdings account for 83% of the portfolio.
Wildcat Capital Management deployed $101M of net new capital in Q2 2019, opening 10 new positions and adding to 8 existing holdings. Its largest new stake was Allogene Therapeutics: 532,166 shares worth $14.3M.
By sector, the portfolio is most concentrated in Real Estate at 29% of assets, down from 36% a quarter earlier, followed by Healthcare and Energy.
On the sell side, the largest reduction was CoStar Group, an estimated $6.68M trimmed.
- Wildcat Capital Management's largest Q2 2019 buy was Allogene Therapeutics: 532,166 shares worth $14.3M.
- Wildcat Capital Management added most to SPDR Gold Trust in Q2 2019, an estimated $16.3M increase.
- Wildcat Capital Management's biggest Q2 2019 reduction was CoStar Group, cutting an estimated $6.68M.
- Wildcat Capital Management fully exited LPL Financial in Q2 2019, selling an estimated $7.08M.
- Wildcat Capital Management's ten largest holdings make up 83% of its $231M portfolio in Q2 2019.
- Wildcat Capital Management opened 10 new positions and closed 2 in Q2 2019.
- Wildcat Capital Management's portfolio value rose 35% quarter-over-quarter to $231M.
Based on Wildcat Capital Management's 13F filing for Q2 2019, filed 14 Aug 2019.